Global Point of Care Diagnostics (POCD) Market Growth (Status and Outlook) 2024-2030--LP INFORMATION, INC.

Global Point of Care Diagnostics (POCD) Market Growth (Status and Outlook) 2024-2030

Product Code: 793472

Industry: Medical Care

Published: Jan 02,2024

Pages: 150

Delivery Time: 2-3 business days

Global Point of Care Diagnostics (POCD) Market Growth (Status and Outlook) 2024-2030

Product Code: 793472

Industry: Medical Care

Published: Jan 02,2024

Pages: 150

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to our LPI (LP Information) latest study, the global Point of Care Diagnostics (POCD) market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the Point of Care Diagnostics (POCD) is forecast to a readjusted size of US$ 34320 million by 2030 with a CAGR of 4.6% during review period.

The research report highlights the growth potential of the global Point of Care Diagnostics (POCD) market.  Point of Care Diagnostics (POCD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point of Care Diagnostics (POCD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point of Care Diagnostics (POCD) market.

Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on Point of Care Diagnostics (POCD) market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Point of Care Diagnostics (POCD) market. It may include historical data, market segmentation by Type (e.g., Blood Glucose Testing, Infectious Diseases Testing), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point of Care Diagnostics (POCD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Point of Care Diagnostics (POCD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Point of Care Diagnostics (POCD) industry. This include advancements in Point of Care Diagnostics (POCD) technology, Point of Care Diagnostics (POCD) new entrants, Point of Care Diagnostics (POCD) new investment, and other innovations that are shaping the future of Point of Care Diagnostics (POCD).

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point of Care Diagnostics (POCD) market. It includes factors influencing customer ' purchasing decisions, preferences for Point of Care Diagnostics (POCD) product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point of Care Diagnostics (POCD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point of Care Diagnostics (POCD) market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point of Care Diagnostics (POCD) market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point of Care Diagnostics (POCD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point of Care Diagnostics (POCD) market.

Market Segmentation:

Point of Care Diagnostics (POCD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

    Blood Glucose Testing

    Infectious Diseases Testing

    Cardiac Markers Testing

    Coagulation Testing

    Pregnancy and Fertility Testing

    Blood Gas/Electrolytes Testing

    Tumor Markers Testing

    Urinalysis Testing

    Cholesterol Testing

    Others

Segmentation by application

    Clinics

    Hospitals

    Assisted Living Healthcare Facilities

    Laboratory

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Alere

    Roche

    Abbott Laboratories

    Johnson & Johnson

    Siemens Healthcare

    Danaher

    QIAGEN

    Bayer Healthcare

    Beckman Coulter

    Nipro Diagnostics

    Bio-Rad Laboratories

    Nova Biomedical

    BioMerieux

    Quidel

    Helena Laboratories

    OraSure Technologies

    Accriva

    Abaxis

    Chembio Diagnostics

    Trinity Biotech

    Instrumentation Laboratory

    Sekisui Diagnostics

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Point of Care Diagnostics (POCD) Market Size 2019-2030
        2.1.2 Point of Care Diagnostics (POCD) Market Size CAGR by Region 2019 VS 2023 VS 2030
    2.2 Point of Care Diagnostics (POCD) Segment by Type
        2.2.1 Blood Glucose Testing
        2.2.2 Infectious Diseases Testing
        2.2.3 Cardiac Markers Testing
        2.2.4 Coagulation Testing
        2.2.5 Pregnancy and Fertility Testing
        2.2.6 Blood Gas/Electrolytes Testing
        2.2.7 Tumor Markers Testing
        2.2.8 Urinalysis Testing
        2.2.9 Cholesterol Testing
        2.2.10 Others
    2.3 Point of Care Diagnostics (POCD) Market Size by Type
        2.3.1 Point of Care Diagnostics (POCD) Market Size CAGR by Type (2019 VS 2023 VS 2030)
        2.3.2 Global Point of Care Diagnostics (POCD) Market Size Market Share by Type (2019-2024)
    2.4 Point of Care Diagnostics (POCD) Segment by Application
        2.4.1 Clinics
        2.4.2 Hospitals
        2.4.3 Assisted Living Healthcare Facilities
        2.4.4 Laboratory
    2.5 Point of Care Diagnostics (POCD) Market Size by Application
        2.5.1 Point of Care Diagnostics (POCD) Market Size CAGR by Application (2019 VS 2023 VS 2030)
        2.5.2 Global Point of Care Diagnostics (POCD) Market Size Market Share by Application (2019-2024)

3 Point of Care Diagnostics (POCD) Market Size by Player
    3.1 Point of Care Diagnostics (POCD) Market Size Market Share by Players
        3.1.1 Global Point of Care Diagnostics (POCD) Revenue by Players (2019-2024)
        3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2019-2024)
    3.2 Global Point of Care Diagnostics (POCD) Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Point of Care Diagnostics (POCD) by Regions
    4.1 Point of Care Diagnostics (POCD) Market Size by Regions (2019-2024)
    4.2 Americas Point of Care Diagnostics (POCD) Market Size Growth (2019-2024)
    4.3 APAC Point of Care Diagnostics (POCD) Market Size Growth (2019-2024)
    4.4 Europe Point of Care Diagnostics (POCD) Market Size Growth (2019-2024)
    4.5 Middle East & Africa Point of Care Diagnostics (POCD) Market Size Growth (2019-2024)

5 Americas
    5.1 Americas Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
    5.2 Americas Point of Care Diagnostics (POCD) Market Size by Type (2019-2024)
    5.3 Americas Point of Care Diagnostics (POCD) Market Size by Application (2019-2024)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Point of Care Diagnostics (POCD) Market Size by Region (2019-2024)
    6.2 APAC Point of Care Diagnostics (POCD) Market Size by Type (2019-2024)
    6.3 APAC Point of Care Diagnostics (POCD) Market Size by Application (2019-2024)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Point of Care Diagnostics (POCD) by Country (2019-2024)
    7.2 Europe Point of Care Diagnostics (POCD) Market Size by Type (2019-2024)
    7.3 Europe Point of Care Diagnostics (POCD) Market Size by Application (2019-2024)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Point of Care Diagnostics (POCD) by Region (2019-2024)
    8.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2019-2024)
    8.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2019-2024)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Point of Care Diagnostics (POCD) Market Forecast
    10.1 Global Point of Care Diagnostics (POCD) Forecast by Regions (2025-2030)
        10.1.1 Global Point of Care Diagnostics (POCD) Forecast by Regions (2025-2030)
        10.1.2 Americas Point of Care Diagnostics (POCD) Forecast
        10.1.3 APAC Point of Care Diagnostics (POCD) Forecast
        10.1.4 Europe Point of Care Diagnostics (POCD) Forecast
        10.1.5 Middle East & Africa Point of Care Diagnostics (POCD) Forecast
    10.2 Americas Point of Care Diagnostics (POCD) Forecast by Country (2025-2030)
        10.2.1 United States Point of Care Diagnostics (POCD) Market Forecast
        10.2.2 Canada Point of Care Diagnostics (POCD) Market Forecast
        10.2.3 Mexico Point of Care Diagnostics (POCD) Market Forecast
        10.2.4 Brazil Point of Care Diagnostics (POCD) Market Forecast
    10.3 APAC Point of Care Diagnostics (POCD) Forecast by Region (2025-2030)
        10.3.1 China Point of Care Diagnostics (POCD) Market Forecast
        10.3.2 Japan Point of Care Diagnostics (POCD) Market Forecast
        10.3.3 Korea Point of Care Diagnostics (POCD) Market Forecast
        10.3.4 Southeast Asia Point of Care Diagnostics (POCD) Market Forecast
        10.3.5 India Point of Care Diagnostics (POCD) Market Forecast
        10.3.6 Australia Point of Care Diagnostics (POCD) Market Forecast
    10.4 Europe Point of Care Diagnostics (POCD) Forecast by Country (2025-2030)
        10.4.1 Germany Point of Care Diagnostics (POCD) Market Forecast
        10.4.2 France Point of Care Diagnostics (POCD) Market Forecast
        10.4.3 UK Point of Care Diagnostics (POCD) Market Forecast
        10.4.4 Italy Point of Care Diagnostics (POCD) Market Forecast
        10.4.5 Russia Point of Care Diagnostics (POCD) Market Forecast
    10.5 Middle East & Africa Point of Care Diagnostics (POCD) Forecast by Region (2025-2030)
        10.5.1 Egypt Point of Care Diagnostics (POCD) Market Forecast
        10.5.2 South Africa Point of Care Diagnostics (POCD) Market Forecast
        10.5.3 Israel Point of Care Diagnostics (POCD) Market Forecast
        10.5.4 Turkey Point of Care Diagnostics (POCD) Market Forecast
        10.5.5 GCC Countries Point of Care Diagnostics (POCD) Market Forecast
    10.6 Global Point of Care Diagnostics (POCD) Forecast by Type (2025-2030)
    10.7 Global Point of Care Diagnostics (POCD) Forecast by Application (2025-2030)

11 Key Players Analysis
    11.1 Alere
        11.1.1 Alere Company Information
        11.1.2 Alere Point of Care Diagnostics (POCD) Product Offered
        11.1.3 Alere Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.1.4 Alere Main Business Overview
        11.1.5 Alere Latest Developments
    11.2 Roche
        11.2.1 Roche Company Information
        11.2.2 Roche Point of Care Diagnostics (POCD) Product Offered
        11.2.3 Roche Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.2.4 Roche Main Business Overview
        11.2.5 Roche Latest Developments
    11.3 Abbott Laboratories
        11.3.1 Abbott Laboratories Company Information
        11.3.2 Abbott Laboratories Point of Care Diagnostics (POCD) Product Offered
        11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.3.4 Abbott Laboratories Main Business Overview
        11.3.5 Abbott Laboratories Latest Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Information
        11.4.2 Johnson & Johnson Point of Care Diagnostics (POCD) Product Offered
        11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.4.4 Johnson & Johnson Main Business Overview
        11.4.5 Johnson & Johnson Latest Developments
    11.5 Siemens Healthcare
        11.5.1 Siemens Healthcare Company Information
        11.5.2 Siemens Healthcare Point of Care Diagnostics (POCD) Product Offered
        11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.5.4 Siemens Healthcare Main Business Overview
        11.5.5 Siemens Healthcare Latest Developments
    11.6 Danaher
        11.6.1 Danaher Company Information
        11.6.2 Danaher Point of Care Diagnostics (POCD) Product Offered
        11.6.3 Danaher Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.6.4 Danaher Main Business Overview
        11.6.5 Danaher Latest Developments
    11.7 QIAGEN
        11.7.1 QIAGEN Company Information
        11.7.2 QIAGEN Point of Care Diagnostics (POCD) Product Offered
        11.7.3 QIAGEN Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.7.4 QIAGEN Main Business Overview
        11.7.5 QIAGEN Latest Developments
    11.8 Bayer Healthcare
        11.8.1 Bayer Healthcare Company Information
        11.8.2 Bayer Healthcare Point of Care Diagnostics (POCD) Product Offered
        11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.8.4 Bayer Healthcare Main Business Overview
        11.8.5 Bayer Healthcare Latest Developments
    11.9 Beckman Coulter
        11.9.1 Beckman Coulter Company Information
        11.9.2 Beckman Coulter Point of Care Diagnostics (POCD) Product Offered
        11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.9.4 Beckman Coulter Main Business Overview
        11.9.5 Beckman Coulter Latest Developments
    11.10 Nipro Diagnostics
        11.10.1 Nipro Diagnostics Company Information
        11.10.2 Nipro Diagnostics Point of Care Diagnostics (POCD) Product Offered
        11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.10.4 Nipro Diagnostics Main Business Overview
        11.10.5 Nipro Diagnostics Latest Developments
    11.11 Bio-Rad Laboratories
        11.11.1 Bio-Rad Laboratories Company Information
        11.11.2 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product Offered
        11.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.11.4 Bio-Rad Laboratories Main Business Overview
        11.11.5 Bio-Rad Laboratories Latest Developments
    11.12 Nova Biomedical
        11.12.1 Nova Biomedical Company Information
        11.12.2 Nova Biomedical Point of Care Diagnostics (POCD) Product Offered
        11.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.12.4 Nova Biomedical Main Business Overview
        11.12.5 Nova Biomedical Latest Developments
    11.13 BioMerieux
        11.13.1 BioMerieux Company Information
        11.13.2 BioMerieux Point of Care Diagnostics (POCD) Product Offered
        11.13.3 BioMerieux Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.13.4 BioMerieux Main Business Overview
        11.13.5 BioMerieux Latest Developments
    11.14 Quidel
        11.14.1 Quidel Company Information
        11.14.2 Quidel Point of Care Diagnostics (POCD) Product Offered
        11.14.3 Quidel Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.14.4 Quidel Main Business Overview
        11.14.5 Quidel Latest Developments
    11.15 Helena Laboratories
        11.15.1 Helena Laboratories Company Information
        11.15.2 Helena Laboratories Point of Care Diagnostics (POCD) Product Offered
        11.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.15.4 Helena Laboratories Main Business Overview
        11.15.5 Helena Laboratories Latest Developments
    11.16 OraSure Technologies
        11.16.1 OraSure Technologies Company Information
        11.16.2 OraSure Technologies Point of Care Diagnostics (POCD) Product Offered
        11.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.16.4 OraSure Technologies Main Business Overview
        11.16.5 OraSure Technologies Latest Developments
    11.17 Accriva
        11.17.1 Accriva Company Information
        11.17.2 Accriva Point of Care Diagnostics (POCD) Product Offered
        11.17.3 Accriva Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.17.4 Accriva Main Business Overview
        11.17.5 Accriva Latest Developments
    11.18 Abaxis
        11.18.1 Abaxis Company Information
        11.18.2 Abaxis Point of Care Diagnostics (POCD) Product Offered
        11.18.3 Abaxis Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.18.4 Abaxis Main Business Overview
        11.18.5 Abaxis Latest Developments
    11.19 Chembio Diagnostics
        11.19.1 Chembio Diagnostics Company Information
        11.19.2 Chembio Diagnostics Point of Care Diagnostics (POCD) Product Offered
        11.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.19.4 Chembio Diagnostics Main Business Overview
        11.19.5 Chembio Diagnostics Latest Developments
    11.20 Trinity Biotech
        11.20.1 Trinity Biotech Company Information
        11.20.2 Trinity Biotech Point of Care Diagnostics (POCD) Product Offered
        11.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.20.4 Trinity Biotech Main Business Overview
        11.20.5 Trinity Biotech Latest Developments
    11.21 Instrumentation Laboratory
        11.21.1 Instrumentation Laboratory Company Information
        11.21.2 Instrumentation Laboratory Point of Care Diagnostics (POCD) Product Offered
        11.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.21.4 Instrumentation Laboratory Main Business Overview
        11.21.5 Instrumentation Laboratory Latest Developments
    11.22 Sekisui Diagnostics
        11.22.1 Sekisui Diagnostics Company Information
        11.22.2 Sekisui Diagnostics Point of Care Diagnostics (POCD) Product Offered
        11.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
        11.22.4 Sekisui Diagnostics Main Business Overview
        11.22.5 Sekisui Diagnostics Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
    Table 1. Point of Care Diagnostics (POCD) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
    Table 2. Major Players of Blood Glucose Testing
    Table 3. Major Players of Infectious Diseases Testing
    Table 4. Major Players of Cardiac Markers Testing
    Table 5. Major Players of Coagulation Testing
    Table 6. Major Players of Pregnancy and Fertility Testing
    Table 7. Major Players of Blood Gas/Electrolytes Testing
    Table 8. Major Players of Tumor Markers Testing
    Table 9. Major Players of Urinalysis Testing
    Table 10. Major Players of Cholesterol Testing
    Table 11. Major Players of Others
    Table 12. Point of Care Diagnostics (POCD) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
    Table 13. Global Point of Care Diagnostics (POCD) Market Size by Type (2019-2024) & ($ Millions)
    Table 14. Global Point of Care Diagnostics (POCD) Market Size Market Share by Type (2019-2024)
    Table 15. Point of Care Diagnostics (POCD) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
    Table 16. Global Point of Care Diagnostics (POCD) Market Size by Application (2019-2024) & ($ Millions)
    Table 17. Global Point of Care Diagnostics (POCD) Market Size Market Share by Application (2019-2024)
    Table 18. Global Point of Care Diagnostics (POCD) Revenue by Players (2019-2024) & ($ Millions)
    Table 19. Global Point of Care Diagnostics (POCD) Revenue Market Share by Player (2019-2024)
    Table 20. Point of Care Diagnostics (POCD) Key Players Head office and Products Offered
    Table 21. Point of Care Diagnostics (POCD) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    Table 22. New Products and Potential Entrants
    Table 23. Mergers & Acquisitions, Expansion
    Table 24. Global Point of Care Diagnostics (POCD) Market Size by Regions 2019-2024 & ($ Millions)
    Table 25. Global Point of Care Diagnostics (POCD) Market Size Market Share by Regions (2019-2024)
    Table 26. Global Point of Care Diagnostics (POCD) Revenue by Country/Region (2019-2024) & ($ millions)
    Table 27. Global Point of Care Diagnostics (POCD) Revenue Market Share by Country/Region (2019-2024)
    Table 28. Americas Point of Care Diagnostics (POCD) Market Size by Country (2019-2024) & ($ Millions)
    Table 29. Americas Point of Care Diagnostics (POCD) Market Size Market Share by Country (2019-2024)
    Table 30. Americas Point of Care Diagnostics (POCD) Market Size by Type (2019-2024) & ($ Millions)
    Table 31. Americas Point of Care Diagnostics (POCD) Market Size Market Share by Type (2019-2024)
    Table 32. Americas Point of Care Diagnostics (POCD) Market Size by Application (2019-2024) & ($ Millions)
    Table 33. Americas Point of Care Diagnostics (POCD) Market Size Market Share by Application (2019-2024)
    Table 34. APAC Point of Care Diagnostics (POCD) Market Size by Region (2019-2024) & ($ Millions)
    Table 35. APAC Point of Care Diagnostics (POCD) Market Size Market Share by Region (2019-2024)
    Table 36. APAC Point of Care Diagnostics (POCD) Market Size by Type (2019-2024) & ($ Millions)
    Table 37. APAC Point of Care Diagnostics (POCD) Market Size Market Share by Type (2019-2024)
    Table 38. APAC Point of Care Diagnostics (POCD) Market Size by Application (2019-2024) & ($ Millions)
    Table 39. APAC Point of Care Diagnostics (POCD) Market Size Market Share by Application (2019-2024)
    Table 40. Europe Point of Care Diagnostics (POCD) Market Size by Country (2019-2024) & ($ Millions)
    Table 41. Europe Point of Care Diagnostics (POCD) Market Size Market Share by Country (2019-2024)
    Table 42. Europe Point of Care Diagnostics (POCD) Market Size by Type (2019-2024) & ($ Millions)
    Table 43. Europe Point of Care Diagnostics (POCD) Market Size Market Share by Type (2019-2024)
    Table 44. Europe Point of Care Diagnostics (POCD) Market Size by Application (2019-2024) & ($ Millions)
    Table 45. Europe Point of Care Diagnostics (POCD) Market Size Market Share by Application (2019-2024)
    Table 46. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Region (2019-2024) & ($ Millions)
    Table 47. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Market Share by Region (2019-2024)
    Table 48. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2019-2024) & ($ Millions)
    Table 49. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Market Share by Type (2019-2024)
    Table 50. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2019-2024) & ($ Millions)
    Table 51. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Market Share by Application (2019-2024)
    Table 52. Key Market Drivers & Growth Opportunities of Point of Care Diagnostics (POCD)
    Table 53. Key Market Challenges & Risks of Point of Care Diagnostics (POCD)
    Table 54. Key Industry Trends of Point of Care Diagnostics (POCD)
    Table 55. Global Point of Care Diagnostics (POCD) Market Size Forecast by Regions (2025-2030) & ($ Millions)
    Table 56. Global Point of Care Diagnostics (POCD) Market Size Market Share Forecast by Regions (2025-2030)
    Table 57. Global Point of Care Diagnostics (POCD) Market Size Forecast by Type (2025-2030) & ($ Millions)
    Table 58. Global Point of Care Diagnostics (POCD) Market Size Forecast by Application (2025-2030) & ($ Millions)
    Table 59. Alere Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 60. Alere Point of Care Diagnostics (POCD) Product Offered
    Table 61. Alere Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 62. Alere Main Business
    Table 63. Alere Latest Developments
    Table 64. Roche Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 65. Roche Point of Care Diagnostics (POCD) Product Offered
    Table 66. Roche Main Business
    Table 67. Roche Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 68. Roche Latest Developments
    Table 69. Abbott Laboratories Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 70. Abbott Laboratories Point of Care Diagnostics (POCD) Product Offered
    Table 71. Abbott Laboratories Main Business
    Table 72. Abbott Laboratories Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 73. Abbott Laboratories Latest Developments
    Table 74. Johnson & Johnson Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 75. Johnson & Johnson Point of Care Diagnostics (POCD) Product Offered
    Table 76. Johnson & Johnson Main Business
    Table 77. Johnson & Johnson Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 78. Johnson & Johnson Latest Developments
    Table 79. Siemens Healthcare Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 80. Siemens Healthcare Point of Care Diagnostics (POCD) Product Offered
    Table 81. Siemens Healthcare Main Business
    Table 82. Siemens Healthcare Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 83. Siemens Healthcare Latest Developments
    Table 84. Danaher Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 85. Danaher Point of Care Diagnostics (POCD) Product Offered
    Table 86. Danaher Main Business
    Table 87. Danaher Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 88. Danaher Latest Developments
    Table 89. QIAGEN Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 90. QIAGEN Point of Care Diagnostics (POCD) Product Offered
    Table 91. QIAGEN Main Business
    Table 92. QIAGEN Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 93. QIAGEN Latest Developments
    Table 94. Bayer Healthcare Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 95. Bayer Healthcare Point of Care Diagnostics (POCD) Product Offered
    Table 96. Bayer Healthcare Main Business
    Table 97. Bayer Healthcare Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 98. Bayer Healthcare Latest Developments
    Table 99. Beckman Coulter Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 100. Beckman Coulter Point of Care Diagnostics (POCD) Product Offered
    Table 101. Beckman Coulter Main Business
    Table 102. Beckman Coulter Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 103. Beckman Coulter Latest Developments
    Table 104. Nipro Diagnostics Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 105. Nipro Diagnostics Point of Care Diagnostics (POCD) Product Offered
    Table 106. Nipro Diagnostics Main Business
    Table 107. Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 108. Nipro Diagnostics Latest Developments
    Table 109. Bio-Rad Laboratories Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 110. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product Offered
    Table 111. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 112. Bio-Rad Laboratories Main Business
    Table 113. Bio-Rad Laboratories Latest Developments
    Table 114. Nova Biomedical Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 115. Nova Biomedical Point of Care Diagnostics (POCD) Product Offered
    Table 116. Nova Biomedical Main Business
    Table 117. Nova Biomedical Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 118. Nova Biomedical Latest Developments
    Table 119. BioMerieux Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 120. BioMerieux Point of Care Diagnostics (POCD) Product Offered
    Table 121. BioMerieux Main Business
    Table 122. BioMerieux Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 123. BioMerieux Latest Developments
    Table 124. Quidel Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 125. Quidel Point of Care Diagnostics (POCD) Product Offered
    Table 126. Quidel Main Business
    Table 127. Quidel Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 128. Quidel Latest Developments
    Table 129. Helena Laboratories Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 130. Helena Laboratories Point of Care Diagnostics (POCD) Product Offered
    Table 131. Helena Laboratories Main Business
    Table 132. Helena Laboratories Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 133. Helena Laboratories Latest Developments
    Table 134. OraSure Technologies Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 135. OraSure Technologies Point of Care Diagnostics (POCD) Product Offered
    Table 136. OraSure Technologies Main Business
    Table 137. OraSure Technologies Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 138. OraSure Technologies Latest Developments
    Table 139. Accriva Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 140. Accriva Point of Care Diagnostics (POCD) Product Offered
    Table 141. Accriva Main Business
    Table 142. Accriva Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 143. Accriva Latest Developments
    Table 144. Abaxis Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 145. Abaxis Point of Care Diagnostics (POCD) Product Offered
    Table 146. Abaxis Main Business
    Table 147. Abaxis Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 148. Abaxis Latest Developments
    Table 149. Chembio Diagnostics Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 150. Chembio Diagnostics Point of Care Diagnostics (POCD) Product Offered
    Table 151. Chembio Diagnostics Main Business
    Table 152. Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 153. Chembio Diagnostics Latest Developments
    Table 154. Trinity Biotech Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 155. Trinity Biotech Point of Care Diagnostics (POCD) Product Offered
    Table 156. Trinity Biotech Main Business
    Table 157. Trinity Biotech Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 158. Trinity Biotech Latest Developments
    Table 159. Instrumentation Laboratory Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 160. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product Offered
    Table 161. Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 162. Instrumentation Laboratory Main Business
    Table 163. Instrumentation Laboratory Latest Developments
    Table 164. Sekisui Diagnostics Details, Company Type, Point of Care Diagnostics (POCD) Area Served and Its Competitors
    Table 165. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product Offered
    Table 166. Sekisui Diagnostics Main Business
    Table 167. Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 168. Sekisui Diagnostics Latest Developments
List of Figures
    Figure 1. Point of Care Diagnostics (POCD) Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Point of Care Diagnostics (POCD) Market Size Growth Rate 2019-2030 ($ Millions)
    Figure 6. Point of Care Diagnostics (POCD) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
    Figure 7. Point of Care Diagnostics (POCD) Sales Market Share by Country/Region (2023)
    Figure 8. Point of Care Diagnostics (POCD) Sales Market Share by Country/Region (2019, 2023 & 2030)
    Figure 9. Global Point of Care Diagnostics (POCD) Market Size Market Share by Type in 2023
    Figure 10. Point of Care Diagnostics (POCD) in Clinics
    Figure 11. Global Point of Care Diagnostics (POCD) Market: Clinics (2019-2024) & ($ Millions)
    Figure 12. Point of Care Diagnostics (POCD) in Hospitals
    Figure 13. Global Point of Care Diagnostics (POCD) Market: Hospitals (2019-2024) & ($ Millions)
    Figure 14. Point of Care Diagnostics (POCD) in Assisted Living Healthcare Facilities
    Figure 15. Global Point of Care Diagnostics (POCD) Market: Assisted Living Healthcare Facilities (2019-2024) & ($ Millions)
    Figure 16. Point of Care Diagnostics (POCD) in Laboratory
    Figure 17. Global Point of Care Diagnostics (POCD) Market: Laboratory (2019-2024) & ($ Millions)
    Figure 18. Global Point of Care Diagnostics (POCD) Market Size Market Share by Application in 2023
    Figure 19. Global Point of Care Diagnostics (POCD) Revenue Market Share by Player in 2023
    Figure 20. Global Point of Care Diagnostics (POCD) Market Size Market Share by Regions (2019-2024)
    Figure 21. Americas Point of Care Diagnostics (POCD) Market Size 2019-2024 ($ Millions)
    Figure 22. APAC Point of Care Diagnostics (POCD) Market Size 2019-2024 ($ Millions)
    Figure 23. Europe Point of Care Diagnostics (POCD) Market Size 2019-2024 ($ Millions)
    Figure 24. Middle East & Africa Point of Care Diagnostics (POCD) Market Size 2019-2024 ($ Millions)
    Figure 25. Americas Point of Care Diagnostics (POCD) Value Market Share by Country in 2023
    Figure 26. United States Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 27. Canada Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 28. Mexico Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 29. Brazil Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 30. APAC Point of Care Diagnostics (POCD) Market Size Market Share by Region in 2023
    Figure 31. APAC Point of Care Diagnostics (POCD) Market Size Market Share by Type in 2023
    Figure 32. APAC Point of Care Diagnostics (POCD) Market Size Market Share by Application in 2023
    Figure 33. China Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 34. Japan Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 35. Korea Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 36. Southeast Asia Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 37. India Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 38. Australia Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 39. Europe Point of Care Diagnostics (POCD) Market Size Market Share by Country in 2023
    Figure 40. Europe Point of Care Diagnostics (POCD) Market Size Market Share by Type (2019-2024)
    Figure 41. Europe Point of Care Diagnostics (POCD) Market Size Market Share by Application (2019-2024)
    Figure 42. Germany Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 43. France Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 44. UK Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 45. Italy Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 46. Russia Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 47. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Market Share by Region (2019-2024)
    Figure 48. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Market Share by Type (2019-2024)
    Figure 49. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Market Share by Application (2019-2024)
    Figure 50. Egypt Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 51. South Africa Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 52. Israel Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 53. Turkey Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 54. GCC Country Point of Care Diagnostics (POCD) Market Size Growth 2019-2024 ($ Millions)
    Figure 55. Americas Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 56. APAC Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 57. Europe Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 58. Middle East & Africa Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 59. United States Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 60. Canada Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 61. Mexico Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 62. Brazil Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 63. China Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 64. Japan Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 65. Korea Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 66. Southeast Asia Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 67. India Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 68. Australia Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 69. Germany Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 70. France Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 71. UK Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 72. Italy Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 73. Russia Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 74. Spain Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 75. Egypt Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 76. South Africa Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 77. Israel Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 78. Turkey Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 79. GCC Countries Point of Care Diagnostics (POCD) Market Size 2025-2030 ($ Millions)
    Figure 80. Global Point of Care Diagnostics (POCD) Market Size Market Share Forecast by Type (2025-2030)
    Figure 81. Global Point of Care Diagnostics (POCD) Market Size Market Share Forecast by Application (2025-2030)

Companies Mentioned

Alere

Roche

Abbott Laboratories

Johnson & Johnson

Siemens Healthcare

Danaher

QIAGEN

Bayer Healthcare

Beckman Coulter

Nipro Diagnostics

Bio-Rad Laboratories

Nova Biomedical

BioMerieux

Quidel

Helena Laboratories

OraSure Technologies

Accriva

Abaxis

Chembio Diagnostics

Trinity Biotech

Instrumentation Laboratory

Sekisui Diagnostics

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff